Next Biomedical
Nano-based drug delivery for interventional medicine
Next Biomedical was founded in 2014 and is headquartered in Incheon, South Korea.
- Headquarters
- Incheon
- Founded
- 2014
- Business Model
- B2B
- Website
- nextbiomedical.co.kr
About
Next Biomedical (NEXTBIOMEDICAL) is a South Korean medical device company founded in 2014 and listed on KOSDAQ (389650). Headquartered in Incheon, South Korea, the company specializes in nano-based drug delivery systems and therapeutic materials for interventional medical procedures. Its core technology platform enables minimally invasive treatment across gastrointestinal, vascular, and orthopedic applications. Notable products include Nexpowder, a hemostatic powder agent designed for gastrointestinal bleeding. The company combines biomedical materials science with drug delivery innovation to develop next-generation medical devices for clinical use in interventional medicine.
Summary
Next Biomedical is a Biotech company based in Incheon, South Korea, founded in 2014.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/next-biomedical"><img src="https://indexed.vc/api/badge/company/next-biomedical" alt="Next Biomedical on Indexed.vc" width="260" height="76" /></a>